", "sentences": [], "annotations": [], "relations": []}, {"offset": 27181, "infons": {"section_type": "CONCL", "type": "title_1"}, "text": "Conclusions", "sentences": [], "annotations": [], "relations": []}, {"offset": 27193, "infons": {"section_type": "CONCL", "type": "paragraph"}, "text": "These studies in melanoma cell lines may allow to better interpret the results of a recently reported phase I clinical trial with PLX4032, with an objective response in excess of 70% of patients with BRAFV600E positive metastatic melanoma. The characterization of PLX4032-sensitive and -resistant BRAFV600E mutant melanoma cell lines may provide information about the molecular mechanisms that dictate sensitivity and resistance to PLX4032. In addition, molecular imaging with [18F]FDG PET scans may help in providing an early readout of complete or incomplete pharmacodynamic effects of PLX4032 and therefore predict lesions that may or may not respond to therapy.", "sentences": [], "annotations": [], "relations": []}, {"offset": 27859, "infons": {"section_type": "ABBR", "type": "title_1"}, "text": "Abbreviations", "sentences": [], "annotations": [], "relations": []}, {"offset": 27873, "infons": {"section_type": "ABBR", "type": "paragraph"}, "text": "(BRK): Breast tumor kinase; (MKPs/DUSPs): Dual specificity phosphatases; (FDG): 2-fluoro-2-deoxy-D-glucose; (FAC): 2'-Deoxy-2'-fluoroarabinofuranosylcytosine-[3H]; (MTA): Materials transfer agreement; (MTS): 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; (IC50): Half maximal inhibitory concentration; (MAPK): Mitogen-activated protein kinase; (pErk): Phosphorylated Erk; (PET): Positron emission tomography; (thymidine): Thymidine [methyl-3H]; (UCLA): University of California Los Angeles.", "sentences": [], "annotations": [], "relations": []}, {"offset": 28407, "infons": {"section_type": "COMP_INT", "type": "title_1"}, "text": "Competing interests", "sentences": [], "annotations": [], "relations": []}, {"offset": 28427, "infons": {"section_type": "COMP_INT", "type": "paragraph"}, "text": "The authors declare that they have no competing interests.", "sentences": [], "annotations": [], "relations": []}, {"offset": 28486, "infons": {"section_type": "AUTH_CONT", "type": "title_1"}, "text": "Authors' contributions", "sentences": [], "annotations": [], "relations": []}, {"offset": 28509, "infons": {"section_type": "AUTH_CONT", "type": "paragraph"}, "text": "JNS, RN, QW, DG, TH, SM, HS, LEM, JGB, SK, NA, EVE, JZ, BC, BAC, RCK: Performed experiments.", "sentences": [], "annotations": [], "relations": []}, {"offset": 28602, "infons": {"section_type": "AUTH_CONT", "type": "paragraph"}, "text": "JNS, PMRSL, AR: Planned the studies and wrote the manuscript.", "sentences": [], "annotations": [], "relations": []}, {"offset": 28664, "infons": {"section_type": "AUTH_CONT", "type": "paragraph"}, "text": "All authors have read and approved the final manuscript.", "sentences": [], "annotations": [], "relations": []}, {"offset": 28721, "infons": {"section_type": "ACK_FUND", "type": "title_1"}, "text": "Acknowledgements", "sentences": [], "annotations": [], "relations": []}, {"offset": 28738, "infons": {"section_type": "ACK_FUND", "type": "paragraph"}, "text": "We would like to thank Dr. Gideon Bollag from Plexxikon for providing PLX4032 and for helpful discussions regarding these studies. We would also like to thank Drs. William Tap and Dennis Slamon at UCLA, and Peter Hirth at Plexxikon for helpful discussions. This work was funded in part by the Jonsson Cancer Center Foundation (JCCF), the NIH award P50 CA086306 and by the Caltech-UCLA Joint Center for Translational Medicine (to AR); and the Dermatology Foundation, the STOP CANCER Foundation and the Burroughs Welcome Fund (to RSL).", "sentences": [], "annotations": [], "relations": []}, {"offset": 29272, "infons": {"fpage": "851", "lpage": "857", "name_0": "surname:Gray-Schopfer;given-names:V", "name_1": "surname:Wellbrock;given-names:C", "name_2": "surname:Marais;given-names:R", "pub-id_doi": "10.1038/nature05661", "pub-id_pmid": "17314971", "section_type": "REF", "source": "Nature", "type": "ref", "volume": "445", "year": "2007"}, "text": "Melanoma biology and new targeted therapy", "sentences": [], "annotations": [], "relations": []}, {"offset": 29314, "infons": {"fpage": "3241", "lpage": "3244", "name_0": "surname:Smalley;given-names:KS", "name_1": "surname:Nathanson;given-names:KL", "name_2": "surname:Flaherty;given-names:KT", "pub-id_doi": "10.1158/0008-5472.